dc.contributor.author | Bertoletti, A | en_US |
dc.contributor.author | Kennedy, PTF | en_US |
dc.contributor.author | Durantel, D | en_US |
dc.date.accessioned | 2018-01-30T11:27:23Z | |
dc.date.available | 2017-11-24 | en_US |
dc.date.issued | 2018-05 | en_US |
dc.date.submitted | 2018-01-30T10:05:28.614Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/31845 | |
dc.description.sponsorship | Singapore Translational Research (STaR) Investigator Award (NMRC/STaR/013/2012). | en_US |
dc.format.extent | 787 - 788 | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Gut | en_US |
dc.subject | hepatitis b | en_US |
dc.subject | hepatocellular carcinoma | en_US |
dc.subject | Carcinoma, Hepatocellular | en_US |
dc.subject | Hepatitis B virus | en_US |
dc.subject | Hepatitis B, Chronic | en_US |
dc.subject | Humans | en_US |
dc.subject | Liver Neoplasms | en_US |
dc.title | HBV infection and HCC: the 'dangerous liaisons'. | en_US |
dc.type | Article | |
dc.rights.holder | © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. | |
dc.identifier.doi | 10.1136/gutjnl-2017-315528 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29196438 | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 67 | en_US |
dcterms.dateAccepted | 2017-11-24 | en_US |